SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-215941
Filing Date
2023-08-18
Accepted
2023-08-18 16:02:27
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d596479ds3.htm S-3 264985
2 EX-5.1 d596479dex51.htm EX-5.1 8068
3 EX-23.1 d596479dex231.htm EX-23.1 1537
4 EX-FILING FEES d596479dexfilingfees.htm EX-FILING FEES 25994
5 GRAPHIC g596479g0814220845024.jpg GRAPHIC 2649
6 GRAPHIC g596479g0817072909591.jpg GRAPHIC 3390
  Complete submission text file 0001193125-23-215941.txt   310167
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274072 | Film No.: 231185832
SIC: 2836 Biological Products, (No Diagnostic Substances)